InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: locicat1 post# 11679

Wednesday, 02/05/2020 2:56:30 PM

Wednesday, February 05, 2020 2:56:30 PM

Post# of 18220
Mr. Handley indicated in the December 16, 2019 PR Wire release "...Aletheia's diverse oncology product pipeline...." Does anyone have any information as to what are the "products" in this pipeline?? Any information, i.e. chemical names, etc.?? Since it was announced that IMUN will acquire Aletheia in an all-stock transaction it seems as IMUN shareholders it would be more than appropriate to know what these "products" are, etc., as they would be the major/only assets of the transaction.